| The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure P van der Meer, D Postmus, P Ponikowski, JG Cleland, CM O'Connor, ... Journal of the American College of Cardiology 61 (19), 1973-1981, 2013 | 206 | 2013 |
| Prognostic value of serial ST2 measurements in patients with acute heart failure LC van Vark, I Lesman-Leegte, SJ Baart, D Postmus, YM Pinto, JG Orsel, ... Journal of the American College of Cardiology 70 (19), 2378-2388, 2017 | 196 | 2017 |
| Hit-and-run enables efficient weight generation for simulation-based multiple criteria decision analysis T Tervonen, G van Valkenhoef, N Baştürk, D Postmus European Journal of Operational Research 224 (3), 552-559, 2013 | 167 | 2013 |
| Effect of dapagliflozin on clinical outcomes in patients with chronic kidney disease, with and without cardiovascular disease JJV McMurray, DC Wheeler, BV Stefánsson, N Jongs, D Postmus, ... Circulation 143 (5), 438-448, 2021 | 150 | 2021 |
| A stochastic multicriteria model for evidence‐based decision making in drug benefit‐risk analysis T Tervonen, G Van Valkenhoef, E Buskens, HL Hillege, D Postmus Statistics in Medicine 30 (12), 1419-1428, 2011 | 147 | 2011 |
| Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial JM Ter Maaten, IE Beldhuis, P van der Meer, JA Krikken, D Postmus, ... Nature Medicine 29 (10), 2625-2632, 2023 | 144 | 2023 |
| Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study J Biegus, HL Hillege, D Postmus, MAE Valente, DM Bloomfield, ... European journal of heart failure 18 (7), 830-839, 2016 | 123 | 2016 |
| Effects of dapagliflozin in patients with kidney disease, with and without heart failure JJV McMurray, DC Wheeler, BV Stefánsson, N Jongs, D Postmus, ... Heart Failure 9 (11), 807-820, 2021 | 121 | 2021 |
| Understanding patients' preferences: a systematic review of psychological instruments used in patients' preference and decision studies S Russo, C Jongerius, F Faccio, SFM Pizzoli, CA Pinto, J Veldwijk, ... Value in Health 22 (4), 491-501, 2019 | 114 | 2019 |
| A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt … HJL Heerspink, D Cherney, D Postmus, BV Stefánsson, GM Chertow, ... Kidney International 101 (1), 174-184, 2022 | 112* | 2022 |
| Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer J Widder, D Postmus, JF Ubbels, EM Wiegman, JA Langendijk International Journal of Radiation Oncology* Biology* Physics 81 (4), e291-e297, 2011 | 112 | 2011 |
| Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study A Abbasi, E Corpeleijn, E Meijer, D Postmus, RT Gansevoort, ROB Gans, ... Diabetologia 55 (7), 1963-1970, 2012 | 100 | 2012 |
| Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome A Abbasi, E Corpeleijn, D Postmus, RT Gansevoort, PE De Jong, ... The Journal of Clinical Endocrinology & Metabolism 95 (9), E26-E31, 2010 | 93 | 2010 |
| Incorporating patient preferences into drug development and regulatory decision making: results from a quantitative pilot study with cancer patients, carers, and regulators D Postmus, M Mavris, HL Hillege, T Salmonson, B Ryll, A Plate, I Moulon, ... Clinical Pharmacology & Therapeutics 99 (5), 548-554, 2016 | 86 | 2016 |
| Long-term compliance with nonpharmacologic treatment of patients with heart failure MMW Nieuwenhuis, T Jaarsma, DJ van Veldhuisen, D Postmus, ... The American journal of cardiology 110 (3), 392-397, 2012 | 86 | 2012 |
| Multicriteria benefit–risk assessment using network meta-analysis G van Valkenhoef, T Tervonen, J Zhao, B de Brock, HL Hillege, ... Journal of clinical epidemiology 65 (4), 394-403, 2012 | 86 | 2012 |
| Renal function trajectories and clinical outcomes in acute heart failure MM Givertz, D Postmus, HL Hillege, GA Mansoor, BM Massie, BA Davison, ... Circulation: Heart Failure 7 (1), 59-67, 2014 | 81 | 2014 |
| Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure N van Boven, I Kardys, LC van Vark, KM Akkerhuis, MWJ de Ronde, ... European journal of heart failure 20 (1), 89-96, 2018 | 78 | 2018 |
| The COACH risk engine: a multistate model for predicting survival and hospitalization in patients with heart failure D Postmus, DJ van Veldhuisen, T Jaarsma, ML Luttik, J Lassus, ... European journal of heart failure 14 (2), 168-175, 2012 | 78 | 2012 |
| The WAP four-disulfide core domain protein HE4: a novel biomarker for heart failure RA De Boer, Q Cao, D Postmus, K Damman, AA Voors, T Jaarsma, ... JACC: Heart Failure 1 (2), 164-169, 2013 | 75 | 2013 |
Tommi TervonenChief Scientist at Kielo ResearchVerified email at kieloresearch.com
